General Info
Overview
Thymidine kinase 2 deficiency is a form of mitochondrial DNA depletion syndrome. TK2d is an enzyme deficiency. It is a genetic disease that is defined by muscle weakness (myopathy), with effects like difficulty breathing, droopy or saggy eyelids, or trouble chewing and swallowing. It can take a long time before a person is diagnosed with TK2d. Because TK2d is such a rare disease, doctors are just beginning to learn about it. Also, muscle weakness is a sign of many diseases, so there are many disorders for doctors to think about and check for.
Alternative Names
- TK2 deficiency
- TK2d
Frequency
Affected Biological Gender
Male
Signs and Symptoms
Infantile/Childhood Onset
Around 80% of TK2d patients have onset in childhood. TK2d may start as early as the first year of life through the early teenage years. The infantile/childhood form of TK2d is the most severe and often gets worse very fast. Generally, the earlier in life symptoms start the quicker symptoms progress.
Symptoms may include:
- Muscle weakness that gets worse over time
- Low muscle tone (hypotonia—also called floppy baby syndrome)
- Trouble breathing
- Problems chewing and swallowing
- Loss of motor skills (like crawling, walking, balancing, and grabbing)
- Poor reflexes
- Neurological effects, such as seizures or altered brain activity and function
- Slowed mental development
- Hearing loss
When showing up in older children, TK2d develops more slowly and may also include more symptoms, such as:
- Droopy eyelids (ptosis)
- The inability to move the eyes and eyebrows (progressive external ophthalmoplegia, or PEO)
Adult Onset
This type represents around 20% of cases. TK2d can also start in the teenage years through adulthood. The first signs might be when you notice it’s hard to do simple tasks (like climbing stairs) or have shortness of breath. Many people, once diagnosed, look back and realize that there were symptoms earlier in their lives that could be explained by having TK2d. Adult-onset TK2d is still severe, but the progression is slower and more varied.
Symptoms may include:
- Muscle weakness
- Fatigue
- Difficulty walking
- Difficulty breathing
- Droopy eyelids (ptosis)
- The inability to move the eyes and eyebrows (progressive external ophthalmoplegia, or PEO)
- Trouble swallowing (dysphagia)
Diagnosis
Newborn Screening: Recommended Uniform Screening Panel (RUSP)
Yes
Clinical Trials
For specific details on clinical trials visit the MitoAction Clinical Trial page or www.clinicaltrials.gov.
Resources
Connecting with others impacted by a rare disease allows for vital information to be shared about day-to-day life, prevents isolation, and gives hope. Please contact MitoAction for peer support opportunities at 888-MITO-411 or email mito411@mitoaction.org.
Other resources we recommend are:
- New Patient Kit for Mitochondrial Conditions
- Planning for Emergencies
- Monthly Expert Series
- Energy in Action Podcast
MitoAction does not provide medical advice, diagnosis, treatment, or legal advice. It is essential that all those living with or caring for someone with a Mitochondrial or FAOD disease have an emergency protocol letter. These letters, which are written and signed by a doctor, share details about prescribed treatment during crises and in emergency room settings. Always check with your doctor if you or your child has concerns as everyone may present with symptoms differently. Before beginning any treatment or therapy, please consult with your physician.
Last Updated: 11/15/2022